Literature DB >> 17993781

Specific in vivo roles for E2Fs in differentiation and development.

Kelly A McClellan1, Ruth S Slack.   

Abstract

E2Fs have been historically considered as key interacting factors for the retinoblastoma (Rb) family of pocket proteins, acting as universal regulators of cell cycle progression. Often exhibiting overlapping function, deregulated E2F activity is thought to cancer or cell death. While early reports hypothesized that E2Fs may be capable of regulating distinct functions beyond proliferation, several recent reports have characterized increasingly diverse, context dependent functions for different E2Fs in vivo, often in what appears to a manner beyond traditional cell cycle regulation. Ironically, many of these new functions are still mediated through the classical cell cycle regulatory Rb family of interacting factors. Here we review the recent advances, focusing on differentiation and development, to emphasize that E2F function is likely more complex than the simple model suggests, capable of exhibiting both specificity of function, and roles beyond cell cycle progression in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17993781     DOI: 10.4161/cc.6.23.4997

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  37 in total

Review 1.  Cycling or not cycling: cell cycle regulatory molecules and adult neurogenesis.

Authors:  Pierre Beukelaers; Renaud Vandenbosch; Nicolas Caron; Laurent Nguyen; Gustave Moonen; Brigitte Malgrange
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

2.  Rb/E2F regulates expression of neogenin during neuronal migration.

Authors:  Matthew G Andrusiak; Kelly A McClellan; Delphie Dugal-Tessier; Lisa M Julian; Sonia P Rodrigues; David S Park; Timothy E Kennedy; Ruth S Slack
Journal:  Mol Cell Biol       Date:  2010-11-08       Impact factor: 4.272

3.  A novel E2F-like protein involved in transcriptional activation of cyst wall protein genes in Giardia lamblia.

Authors:  Li-Hsin Su; Yu-Jiao Pan; Yu-Chang Huang; Chao-Cheng Cho; Chia-Wei Chen; Shao-Wei Huang; Sheng-Fung Chuang; Chin-Hung Sun
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

4.  Regulation of the Chlamydomonas cell cycle by a stable, chromatin-associated retinoblastoma tumor suppressor complex.

Authors:  Bradley J S C Olson; Michael Oberholzer; Yubing Li; James M Zones; Harjivan S Kohli; Katerina Bisova; Su-Chiung Fang; Jill Meisenhelder; Tony Hunter; James G Umen
Journal:  Plant Cell       Date:  2010-10-26       Impact factor: 11.277

5.  The tumor suppressor Pml regulates cell fate in the developing neocortex.

Authors:  Tarik Regad; Cristian Bellodi; Pierluigi Nicotera; Paolo Salomoni
Journal:  Nat Neurosci       Date:  2009-01-11       Impact factor: 24.884

6.  Tissue-specific targeting of cell fate regulatory genes by E2f factors.

Authors:  L M Julian; Y Liu; C A Pakenham; D Dugal-Tessier; V Ruzhynsky; S Bae; S-Y Tsai; G Leone; R S Slack; A Blais
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

7.  A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence.

Authors:  Srikanth Talluri; Christian E Isaac; Mohammad Ahmad; Shauna A Henley; Sarah M Francis; Alison L Martens; Rod Bremner; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2009-12-14       Impact factor: 4.272

8.  The p107/E2F pathway regulates fibroblast growth factor 2 responsiveness in neural precursor cells.

Authors:  Kelly A McClellan; Jacqueline L Vanderluit; Lisa M Julian; Matthew G Andrusiak; Delphie Dugal-Tessier; David S Park; Ruth S Slack
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

9.  Adenovirus E1A directly targets the E2F/DP-1 complex.

Authors:  Peter Pelka; Matthew S Miller; Matthew Cecchini; Ahmed F Yousef; Dawn M Bowdish; Fred Dick; Peter Whyte; Joe S Mymryk
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

10.  Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3.

Authors:  Julian C Lui; Jeffrey Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.